Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,853.70 +226.40 1.45%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,112.40 -52.97 -1.03%
BREAKING NEWS
Ford to Stop Australia Production from 2016, Cut 1,200 Jobs

BaWang Sues Next Magazine for Defamation Over Shampoo Cancer Risk Report

BaWang International (Group) Holding Ltd., China’s largest herbal shampoo maker, filed a complaint against Next Magazine Publishing Ltd. over a report that said two of its products contain a substance that may cause cancer.

BaWang is seeking unspecified damages from the weekly for “defamation” and “malicious falsehood,” according to the complaint filed in Hong Kong’s High Court July 21. It’s also claiming compensation for loss of sales, it said.

Next Magazine Editor-in-Chief Lee Chi-ho wasn’t available for comment.

BaWang, which uses movie star Jackie Chan and Chinese pop singer Faye Wong to promote its products, slumped 23 percent from July 14 to July 16 after the report said two of the company’s products contain a substance that may cause cancer. The company’s market capitalization declined by HK$3.9 billion in those three trading days.

The herbal shampoo products don’t threaten consumers’ health, China’s State Food and Drug Administration said on July 16.

BaWang rose 0.2 percent to HK$4.90 at 11:43 a.m. in Hong Kong trading.

To contact the reporter on this story: Wendy Leung in Hong Kong at wleung12@bloomberg.net; Debra Mao in Hong Kong at dmao5@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link